Tang L, Cai D, Yan X, Mo W, et al. Second-line chimeric antigen receptor T-cell therapy versus standard of care in relapsed or refractory large B-cell lymphoma: A systematic review and meta-analysis. Cancer 2026;132:e70317.
PMID: 41701615